(Q73919950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

G V McDonnell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C W Kirk

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S A Hawkins

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C A Graham

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

7 November 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

4-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

The soluble interleukin-2 receptor: biology, function, and clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Plasma interleukin 2 receptor levels in renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Soluble interleukin-2 receptors in serum and bile of liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

The role of interleukin 2 in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Significantly higher levels of soluble interleukin 2 in patients with relapsing-remitting multiple sclerosis compared with healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Serum soluble interleukin-2 receptor levels in chronic progressive, stable and steroid-treated multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

A comparison of the pathology of primary and secondary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

An immunogenetic heterogeneity in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Defining the clinical course of multiple sclerosis: Results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Complete nucleotide sequence of the gene for human interleukin 1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Chromosomal localization of the human interleukin 1 alpha (IL-1 alpha) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Dinucleotide repeat polymorphism in the human IL1A gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Dinucleotide repeat polymorphism in the IL2 and IL5RA genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

A polymorphic dinucleotide repeat in the human IL-10 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Interleukin-1 receptor antagonist gene in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Genetic predisposition to multiple sclerosis as revealed by immunoprinting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900291-4

10.1016/S0022-510X(00)00291-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865086%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference